APP and early-onset autosomal dominant Alzheimer disease: In an APP/PS1 transgenic mouse model of Alzheimer's disease, inhibition of HDAC3 in the hippocampus alleviated microglial activation, which showed therapeutic potential for Alzheimer's disease 163.